LVTX - Utang jangka cendhak marang modal Lava Tx

Simbol lan logo merek LAVA Therapeutics (LVTX)

Historical price action for LAVA Therapeutics N.V. (LVTX) on the GURU.Markets platform demonstrates metric levels of 0.00. The brand is renowned for its scientific foundation in developing T-cell therapies to combat solid tumors. Its Gammabody antibody technology attracts partners, which reduces expenses and validates asset value. However, fierce competition from pharma behemoths creates risks of being displaced from the market by more affordable alternatives.

Kewajiban jangka cendhak marang modal: lavatherapeutics.com (LVTX) kanggo 04.07.2022 - 06.12.2025
Produk mawa merek Lava Tx

For LAVA Therapeutics N.V. (LVTX), which is developing the Gammabody platform for cancer therapy, this indicator determines the extent to which capital expenditures for clinical trials depend on borrowed funds. By analyzing the history of short-term loans relative to equity, an investor assesses the proportion of liabilities with a maturity of over one year to net equity, where an increasing ratio signals risks of share devaluation should the issuer's financial stability deteriorate.

Pesaing LAVA Therapeutics N.V. (LVTX)

Utang jangka cendhak marang ekuitas ImmunityBio Corp (IBRX)|Immunocore Corp - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal JANX (Janux Therapeutics)|RCUS - Rasio utang jangka cendhak marang ekuitas|ZYME - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Tango Therapeutics Inc|Iovance (IOVA) - Utang jangka cendhak marang ekuitas|IMTX (Immatics Biotechnologies) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Xencor, Inc.|Kewajiban jangka cendhak marang modal compasstherapeutics.com CMPX|Utang jangka cendhak marang modal REPL|Lyell (LYEL) - Tanggungan utang jangka cendhak marang ekuitas|Innate Pharma, S.A. - Rasio utang jangka cendhak marang ekuitas|Pyxis Oncology Inc. (PYXS) - Kewajiban jangka cendhak marang modal|CGEN: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal IOBT (iobiotech.com)|STRO: Utang jangka cendhak marang modal|INKT - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Werewolf Therapeutics Inc.|Rasio utang jangka cendhak marang ekuitas Immix (IMMX)|Utang jangka cendhak marang ekuitas ALX Oncology (ALXO)|Rasio utang jangka cendhak marang ekuitas Cue Biopharma Inc. CUE|PDS Biotechnology Corporation - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal Sonnet BioTherapeutics Holdings, Inc. SONN|MAIA - Utang jangka cendhak marang ekuitas|LIMN (Liminatus) - Rasio utang jangka cendhak marang modal|NextCure, Inc. (NXTC) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Leap Therapeutics (LPTX)|Rasio utang jangka cendhak marang ekuitas INTS|SNSE - Tanggungan utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas TOVX (Synthetic Biologics)|Rasio silihan jangka cendhak marang modal GRTS|Utang jangka cendhak marang modal KA (Kineta, Inc.)|Rasio tanggungan utang jangka cendhak marang modal NEXI|Turnstone Biologics Corporation - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Vaccinex Inc.|Harpoon Tx (HARP) - Utang jangka cendhak marang ekuitas